Fri, May 27, 2022
Thu, May 26, 2022
Wed, May 25, 2022
Tue, May 24, 2022
Mon, May 23, 2022
Sat, May 21, 2022
Fri, May 20, 2022

Salveen Richter Maintained (BLUE) at Strong Sell with Decreased Target to $2 on, May 24th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-2-on-may-24th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Salveen Richter of Goldman Sachs, Maintained "bluebird bio, Inc." (BLUE) at Strong Sell with Decreased Target from $3 to $2 on, May 24th, 2022.

Salveen has made no other calls on BLUE in the last 4 months.



There are 5 other peers that have a rating on BLUE. Out of the 5 peers that are also analyzing BLUE, 3 agree with Salveen's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Decreased Target to $8 on, Wednesday, April 6th, 2022
  • Yaron Werber of "Cowen & Co." Downgraded from Buy to Hold on, Wednesday, April 6th, 2022
  • Yanan Zhu of "Wells Fargo" Maintained at Hold with Decreased Target to $8 on, Tuesday, March 8th, 2022


These are the ratings of the 2 analyists that currently disagree with Salveen


  • Matthew Harrison of "Morgan Stanley" Maintained at Sell with Decreased Target to $3 on, Tuesday, May 17th, 2022
  • Gena Wang of "Barclays" Maintained at Sell with Decreased Target to $3 on, Tuesday, May 10th, 2022

Publication Contributing Sources